Market Share of Global Adalimumab Drugs Industry
Manufacturers offering biosimilars dominate the global adalimumab drugs market. Companies are focusing on building novel chemical entities and innovative molecules to consolidate their foothold. Some of the prominent market participants are AbbVie Inc; Boehringer Ingelheim GmbH, Novartis AG; Pfizer Inc., F. Hoffmann-La Roche Ltd., Cadila Healthcare Ltd, Hetero Healthcare Limited and Amgen, Inc.
Adalimumab Drugs Market Leaders
AbbVie Inc
Amgen Inc
Cadila Healthcare Ltd
Hetero Healthcare Limited
Pfizer Inc
*Disclaimer: Major Players sorted in no particular order